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Abstract
Background: Genome-wide association studies (GWASs) and global profiling of gene expression (microarrays) are two major
technological breakthroughs that allow hypothesis-free identification of candidate genes associated with tumorigenesis. It
is not obvious whether there is a consistency between the candidate genes identified by GWAS (GWAS genes) and those
identified by profiling gene expression (microarray genes).
Methodology/Principal Findings: We used the Cancer Genetic Markers Susceptibility database to retrieve single nucleotide
polymorphisms from candidate genes for prostate cancer. In addition, we conducted a large meta-analysis of gene
expression data in normal prostate and prostate tumor tissue. We identified 13,905 genes that were interrogated by both
GWASs and microarrays. On the basis of P values from GWASs, we selected 1,649 most significantly associated genes for
functional annotation by the Database for Annotation, Visualization and Integrated Discovery. We also conducted functional
annotation analysis using same number of the top genes identified in the meta-analysis of the gene expression data. We
found that genes involved in cell adhesion were overrepresented among both the GWAS and microarray genes.
Conclusions/Significance: We conclude that the results of these analyses suggest that combining GWAS and microarray
data would be a more effective approach than analyzing individual datasets and can help to refine the identification of
candidate genes and functions associated with tumor development.
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Introduction
Microarray technology allows simultaneous assessment of the
expression of virtually all genes in the genome. This approach has
been widely used to identify candidate genes associated with
cancer development and progression [1–3]. Genome-wide associ-
ation studies (GWASs) have recently emerged as a powerful tool to
identify genetic polymorphisms associated with cancer risk [4,5].
In a GWAS, hundreds of thousands of single nucleotide
polymorphisms (SNPs) are genotyped in a large number of cases
and controls. A difference in allelic or genotype frequencies
between cases and controls suggests an association between cancer
risk and the SNP and a linked gene or regulatory region.
Whether these two approaches produce comparable results has not
been examined. Recently Chen et al. [6] identified the genes that tend
to be differentially expressed across various experiential conditions
and states using gene-expression data from the Gene Expression
Omnibus (GEO). They found that differentially expressed genes are
more likely to be detected as disease variants in association studies.
In this study, we undertook a more direct approach to link
GWAS and microarray data. We performed functional annotations
of the top genes identified in prostate cancer GWASs and the same
number of the top candidate genes identified in a meta-analysis of
the gene-expression data for normal prostate and prostate tumor.
The results of our analyses indicate that these two approaches yield
similar results at the functional level.
Materials and Methods
Several prostate cancer GWASs were recently conducted, and a
number of candidate genes were identified (Table 1) [7–10].
Though only a few SNPs with the genome-wide level of
significance, 10
27, were identified in these studies, a number of
SNPs were significant at the level of individual tests but
nonsignificant after correction for multiple testing. Such SNPs
likely indicate enrichment with causal SNPs that do not reach the
genome-wide significance level because of their small effect size or
low allele frequency [11].
The GWAS data for this analysis were retrieved from the Cancer
Genetic Markers Susceptibility (CGEMS) database, http://cgems.
cancer.gov/about/executive_summary.asp.WeusedtheOncomine
database http://www.oncomine.org/main/index.jsp to conduct a
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normal prostate tissue with that of localized prostate tumor tissue
[12]. The complete list of the studies used in the meta-analysis can
be found in the supplementary materials (Table S1). We used an
extension of Stouffer’s method [13] for the meta-analysis. This
approach is based on estimating the standard normal deviation, Z,
and is similar to the approach recently proposed by Ochsner et al.
[14]. The meta-analysis identified a number of genes differentially
expressed between normal prostate and prostate tumor.
Results
As an initial validation of our hypothesis that GWASs and
microarrays tend to identify the same genes, we used a meta-
analysis of the Oncomine gene-expression data to assess the
expression of the GWAS-identified genes (Table 1). We found that
all but three (HNF1B, EHBP1, and LMTK2) of the genes were
differentially expressed between the normal and tumorous
prostate. Therefore, 10 of 13 (77%) of the GWAS genes were
differentially expressed in the transition from normal prostate to
prostate cancer that is higher than one can expect to detect among
randomly chosen 13 genes 21.1 (x
2=20.9, df=1, P,0.0001).
The prostate cancer GWAS data from CGEMS Phase 1A and
Phase 1B, were used in the analysis. We limited our analysis to the
gene-associated SNPs to make GWAS and microarray results
comparable. We followed the CGEMS designation of the gene-
associated SNPs. A total 63,831 gene-associated SNPs belonging
to 16,550 unique genes were identified. For each gene, a SNP with
the smallest P value was used to characterize an association. If a
given SNP was associated with multiple genes, all those
associations were included in our analysis. Because in many cases
aliases rather than official gene names were used in GWAS, we
linked various gene identifiers to the official gene names and
EntrezIDs using the latest version of the NCBI gene database
(accessed January 17, 2009). Overlapping of the unique GWAS
and microarray genes demonstrated that 13,905 genes were
assessed in both GWAS and microarray analyses. The list of the
genes with corresponding GWAS and microarray P values is
shown in Table S1.
To assess whether the GWAS and microarray analyses tend to
identify similar sets of genes we assess a correlation between –log(P)
values based on GWAS data and –log(P) values based on the
analysis of gene expression. We found a small but significant
(because of the large sample size) positive correlation between
GWAS and microarray –log(P)s (Figure 1).
The Database for Annotation, Visualization and Integrated
Discovery (DAVID) [15] was used for the functional annotation of
GWAS and microarray genes. We selected genes with GWAS P
values #0.01. A total of 1,649 genes were identified. We used
exactly the same number of the top genes identified in the meta-
analysis of the gene-expression data. To control for possible biases
in gene selection, we used the list of 13,905 genes as background.
Functional annotation charts were used to retrieve an extended
annotation coverage that included more than 40 annotation
categories [15]. A functional chart for the top GWAS genes can be
found in Table S2. Many cell adhesion–related categories are
among the top annotation categories. Clustering of the terms of
functional annotations summarized all types of the functional
description used by DAVID, identifying cell adhesion as the top
cluster, followed by plasma membrane and fibronectin.
Functional annotation of the top differentially expressed genes
identified cytoskeleton, focal adhesion, extracellular matrix, and
cell adhesion as the top annotation terms (Table S3). Clustering of
the terms of functional annotation demonstrated cytoskeleton,
actin cytoskeleton, extracellular matrix, and cell adhesion among
the top identified clusters. Figure 2 shows the results of the
clustering of functional terms by DAVID based on the analysis of
the top GWAS and differentially expressed genes (see also Table
S4). In both lists, most of the top functional clusters derived from
GWAS and microarray data are directly or indirectly related to
cell adhesion.
We next looked for an overlap between the top 1,649 GWAS
and the top 1,649 differentially expressed genes. We identified 248
appearing in both lists genes (see supplementary materials for the
list of the genes). This number is higher than would be expected by
chance. If we randomly sample 1,649 genes from among the
13,905 genes, the expected number of the genes found in two
independent samples would be (1,649/13,905) ˆ2*1,649=23.2. The
functional annotation of these 248 genes identified cytoskeleton,
focal adhesion, and actin binding as top functional categories.
Functional clustering of the genes identified cell migration, cell
motility, cytoskeleton, and cell adhesion as the top clusters.
Table 1. Candidate genes identified in prostate cancer GWAS.
Gene GeneID Comparison PMID Microarray Ps
CTBP2 1488 nonaggressive vs. aggressive prostate cancer 18264096 4.6610
26
EHBP1 23301 case control study 18264098 0.63
SLC22A3 6581 case control study 18264097 1.1610
24
LMTK2 22853 case control study 18264097 0.38
KLK2 3817 case control study 18264097 1.4610
27
KLK3 354 case control study 18264097 2.1610
29
NUDT10 170685 case control study 18264097 5.6610
211
DAB2IP 153090 nonaggressive vs. aggressive prostate cancer 18073375 8.0610
27
HNF1B 6928 nonaggressive vs. aggressive prostate cancer 18264096 0.31
HPC1(RNASEL) 6041 controls vs. sporadic prostate cancer 17876339 1.1610
23
JAZF1 221895 nonaggressive vs. aggressive prostate cancer 18264096 1.5610
210
MSMB 4477 nonaggressive vs. aggressive prostate cancer 18264096 4.7610
24
MYC 4609 controls vs. cases 17401366 2.6610
240
doi:10.1371/journal.pone.0006511.t001
GWAS vs Microarrays
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GWAS and microarray analyses both allow unbiased identifi-
cation of candidate genes and pathways associated with cancer
development. These two approaches each have advantages and
drawbacks. By combining data from multiple expression studies,
analyses of gene expressions have the statistical power to detect
even small differences in gene expression between normal and
tumor tissues. On the other hand, because genes in the human
genome are involved in multiple interactions, modulation of the
expression of a single gene may cause a ‘‘ripple effect’’ on multiple
downstream targets, making it difficult to separate causal and
induced changes in gene expression. This is unlikely to be an issue
in GWASs. GWASs, however, are often statistically underpowered
to detect SNPs with small effect size.
When we compared candidate genes for prostate cancer
identified by GWAS with those identified by microarray, we noted
a significant positive correlation between the GWAS and micro-
array –log(P)s. The correlation was small, with the Pearson rank
correlation coefficient being only 0.04, but positive correlation
between two ranks is expected to be driven by a relatively small
number of causal genes. Not all causal genes will be detected by
GWAS. Even if the gene is mechanistically linked to prostate
tumorigenesis, it can be detected by GWAS only if it carries genetic
variants that modulate its function. On the other hand, genes
identified by microarray analysis are expected to be a mix of causal
genes and the genes that are differentially expressed because of the
ripple effect of the causal genes. This suggests that only a fraction of
the genes significant in both analyses are causal genes.
We found that the top GWAS and differentially expressed
candidates were enriched in cell adhesion genes. If we consider all
known cell adhesion genes in the genome, only 74 genes or 10% of
them were among the top differentially expressed genes. If the cell
adhesion pathway is associated with prostate tumorigenesis, one
can expect that other cell adhesion genes—those that did not make
it to the top 1,649 genes—also will tend to be significantly
positively associated. We found that the average GWAS-derived P
value for the cell adhesion genes that failed to reach the top 1649
was lower than the average value for the GWAS genes (t test=2.9,
df=13,902, P=0.001). A similar result was obtained for the P
values derived from the analysis of the gene expression: the
absolute Z score was higher among cell adhesion genes (excluding
those among the top 1649 genes) than was the average Z score (t
test=1.81, df=17811, P=0.07 on the two-tailed test and P=0.03
on the one-tailed test). This suggests that cell adhesion function as
a whole is associated with prostate tumorigenesis.
Both GWAS and microarray genes form functional clusters
related to different aspects of cell adhesion, including cell adhesion
itself, cell junction, extracellular matrix glycoproteins, fibronectin,
actin cytoskeleton, and cell motility. Several other clusters also
show a mechanistic association with cell adhesion. For example,
cadherin uptake from the cell surface by endocytosis regulates the
level of the free cadherins on the cell surface and therefore cell
adhesion [16]. Also, zinc finger proteins with the LIM domain are
important for focal adhesion and cell adhesion to fibronectin
[17,18]. The modulation of the cell adhesion function seems not to
be limited to any specific adhesion type but includes cadherins,
integrins, and selectins as well as adhesion molecules associated
with tight junctions.
The results of a number of studies suggested the involvement of
the cell adhesion system in prostate cancer development.
Cadherins play a role in regulating tumor cell proliferation
through cyclins and cyclin-dependent kinases [19]. Integrins are
involved in different aspects of prostate tumorigenesis, including
cell proliferation, cell motility, and apoptosis [20–22]. Modulation
of cell adhesion can play an important role in epithelial-to-
mesenchymal transition that is believed to be a key step in
malignant transformation [23–25]. Also the results of a number of
studies suggestd an involvement of cell adhesion in angiogenesis
[26–28].
GWAS-identified genes are considered to be cancer susceptibility
genes that are mainly associated with tumor initiation. We believe,
however, that genes identified by GWAS are also likely to include
genes important for tumor progression. Indeed, the detection of
tumor is usually symptomatic: the tumor needs to reach a certain
size to be detected. This suggests that genes involved in tumor
progression will be among GWAS-detected candidate genes.
Therefore, GWAS and gene expression analysis may target
essentially the same set of genes, providing the theoretical basis
for the joint analysis of GWAS and microarray data.
Figure 1. The plot of GWAS and microarray –log(P)s. Black line shows the linear regression curve, red line – moving average computed using a
sliding window of 100 points. Spearman’s rank-order correlation coefficient: r=0.043, N=13905, P=0.0000001.
doi:10.1371/journal.pone.0006511.g001
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prostate cancer genes identified by GWAS and those identified by
global profiling of the gene expression. We identified cell adhesion as a
biological function associated with prostate tumorigenesis. The results
of this study also suggest that combining GWAS and microarray data
might be a more effective approach than using just the analysis of the
individual datasets, and can help to refine the identification of
candidate genes and/or functions involved in tumor development.
Supporting Information
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Table S2
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Figure 2. Clustering of the functional annotation terms based on GWAS- (upper panel) and microarray-derived genes (lower
panel). Functional clusters related to cell adhesion are shown in blue. Detailed information on the composition of clusters can be found in
Table S4.
doi:10.1371/journal.pone.0006511.g002
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